Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

39 results about "Deciliters" patented technology

Detection and determination of the stages of coronary artery disease

A method having clinically sufficient degree of diagnostic accuracy for detecting the presence of coronary artery disease in a human patient from the general population and for distinguishing between the stages of the disease in that patient is disclosed. The stages are, first, the non-acute stage, which is either asymptomatic coronary artery disease or stable angina, second, the acute stage known as unstable angina, and, third, the acute stage known as acute myocardial infarction. The diseased state (as opposed to the non-diseased state) is indicated by the clinically significant presence of a first marker in a sample from the patient. The presence of one of the two acute stages, unstable angina or acute myocardial infarction, is indicated by the clinically significant presence of a second marker in a sample from the patient. The presence of the more severe acute stage known as acute myocardial infarction is indicated by the clinically significant presence of a third marker in a sample from the patient. Preferably the first marker comprises OxLDL, the second marker comprises MDA-modified LDL, and the third marker is a troponin. Preferably the OxLDL and MDA-modified LDL are detected using monoclonal antibodies that can detect the presence of those markers in undiluted human plasma at concentrations as low as 0.02 milligrams/deciliter.
Owner:LEUVEN RES & DEV VZW

Polyester compositions, methods of manufacture, and uses thereof

A composition is disclosed, comprising, based on the total weight of the composition, a combination of from 44 to 80 weight percent of a thermoplastic poly(butylene terephthalate); from 20 to 50 weight percent of a thermoplastic poly(ethylene terephthalate) having an intrinsic viscosity of 0.5 to 0.8 deciliters per gram, measured in a 60:40 by weight phenol / 1,1,2,2-tetrachloroethane mixture at 23° C. using a relative viscometer operating with a closed loop system, which measures the solvent and sample viscosity simultaneously; from 5 to less than 20 weight percent of a talc filler having an average largest dimension of less than 0.9 micrometers, a median particle size of less than 0.9 micrometers, or both; and from 0.1 to 0.5 weight percent of a mold release agent. The compositions are useful in the manufacture of lighting articles, which can be directly metallized without the inclusion of a base coat.
Owner:SABIC GLOBAL TECH BV

Eigen antiflaming semi-aromatic copolymerization aromatic ether amide and preparation method thereof

The invention discloses an eigen antiflaming semi-aromatic copolymerization aromatic ether amide and a preparation method thereof. Diphenol monomer containing phosphorus / silicon or difluoro-malonic acid diamide containing silicon or difluoro-malonic acid diamide monomer containing phosphorus is utilized, and solution polycondensation is carried out to prepare the antiflaming semi-aromatic copolymerization aromatic ether amide. Intrinsic viscosity number [eta] of the semi-aromatic copolymerization aromatic ether amide is 0.65-1.01 deciliters per gram, the vertical flaming class is V-2-V-0, thelimit oxygen index is 26.8-45.5%, and the tensile strength is 65-108 megapascals. The eigen antiflaming semi-aromatic copolymerization aromatic ether amide has the advantages of halogen-free flame retardant, non-molten drop performance, easy processing, high mechanical strength and the like, and the eigen antiflaming semi-aromatic copolymerization aromatic ether amide taken as engineering plasticsis wider in application.
Owner:SICHUAN UNIV

Detection and determination of the stages of coronary artery disease

A method having clinically sufficient degree of diagnostic accuracy for detecting the presence of coronary artery disease in a human patient from the general population and for distinguishing between the stages of the disease in that patient is disclosed. The stages are, first, the non-acute stage, which is either asymptomatic coronary artery disease or stable angina, second, the acute stage known as unstable angina, and, third, the acute stage known as acute myocardial infarction. The diseased state (as opposed to the non-diseased state) is indicated by the clinically significant presence of a first marker in a sample from the patient. The presence of one of the two acute stages, unstable angina or acute myocardial infarction, is indicated by the clinically significant presence of a second marker in a sample from the patient. The presence of the more severe acute stage known as acute myocardial infarction is indicated by the clinically significant presence of a third marker in a sample from the patient. Preferably the first marker comprises OxLDL, the second marker comprises MDA-modified LDL, and the third marker is a troponin. Preferably the OxLDL and MDA-modified LDL are detected using monoclonal antibodies that can detect the presence of those markers in undiluted human plasma at concentrations as low as 0.02 milligrams / deciliter.
Owner:LEUVEN RES & DEV VZW

Varnish compositions for electrical insulation and method of using the same

A varnish composition for producing an electrically insulative thermoset coating is disclosed. The varnish composition includes a functionalized poly(phenylene ether) having at least one aliphatic unsaturated group and exhibiting an intrinsic viscosity in the range of about 0.06 to about 0.25 deciliter per gram, measured in chloroform at 25° C. The varnish composition further includes an unsaturated polyester resin or vinyl ester resin, a reactive liquid monomer, and a compatibilizing agent. When cured, the polymers and reactive liquid monomer form an electrically insulative thermoset.
Owner:SHPP GLOBAL TECH BV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products